Carbon monoxide-releasing mesoporous polydopamine nanoplatform for lysosomal disruption and synergistic tumor therapy.
Lysosomes, pivotal in tumor progression and therapy resistance, sustain cancer survival through drug tolerance and stress adaptation. Conventional lysosome-disrupting approaches faced transient efficacy from poor targeting or cellular repair mechanisms. To address this, we engineered a biomimetic nanoplatform (FeCO@MP-...